AV-1 for Dengue Fever
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical trial is to determine the prophylactic and therapeutic effect of AV-1 in healthy adults using a DENV-3 controlled human infection model (CHIM)
Will I have to stop taking my current medications?
The trial protocol does not specify if you must stop taking your current medications, but it does mention that certain medications are prohibited. These include oral/systemic anti-neoplastic agents, medications that alter drug absorption, metabolism, or elimination, immunosuppressive drugs, aspirin products, and NSAIDs. It's best to discuss your current medications with the trial team to see if they are allowed.
Who Is on the Research Team?
Urban Ramstedt, PhD
Principal Investigator
AbViro LLC
Are You a Good Fit for This Trial?
This trial is for healthy adults who can potentially be exposed to Dengue Virus 3 (DENV-3). Specific eligibility criteria are not provided, but typically participants must meet certain health standards and not have conditions that would exclude them from safely participating.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Prophylaxis
Participants receive AV-1 for prophylactic effect against DENV-3
Treatment
Participants receive AV-1 for therapeutic effect against DENV-3
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- AV-1
Find a Clinic Near You
Who Is Running the Clinical Trial?
AbViro LLC
Lead Sponsor